These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 20848609)

  • 1. Layer-specific alterations to CA1 dendritic spines in a mouse model of Alzheimer's disease.
    Merino-Serrais P; Knafo S; Alonso-Nanclares L; Fernaud-Espinosa I; DeFelipe J
    Hippocampus; 2011 Oct; 21(10):1037-44. PubMed ID: 20848609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Widespread changes in dendritic spines in a model of Alzheimer's disease.
    Knafo S; Alonso-Nanclares L; Gonzalez-Soriano J; Merino-Serrais P; Fernaud-Espinosa I; Ferrer I; DeFelipe J
    Cereb Cortex; 2009 Mar; 19(3):586-92. PubMed ID: 18632740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphological alterations to neurons of the amygdala and impaired fear conditioning in a transgenic mouse model of Alzheimer's disease.
    Knafo S; Venero C; Merino-Serrais P; Fernaud-Espinosa I; Gonzalez-Soriano J; Ferrer I; Santpere G; DeFelipe J
    J Pathol; 2009 Sep; 219(1):41-51. PubMed ID: 19449368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dendritic spine abnormalities in hippocampal CA1 pyramidal neurons underlying memory deficits in the SAMP8 mouse model of Alzheimer's disease.
    del Valle J; Bayod S; Camins A; Beas-Zárate C; Velázquez-Zamora DA; González-Burgos I; Pallàs M
    J Alzheimers Dis; 2012; 32(1):233-40. PubMed ID: 22776969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered synaptic structure in the hippocampus in a mouse model of Alzheimer's disease with soluble amyloid-β oligomers and no plaque pathology.
    Price KA; Varghese M; Sowa A; Yuk F; Brautigam H; Ehrlich ME; Dickstein DL
    Mol Neurodegener; 2014 Oct; 9():41. PubMed ID: 25312309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dendrite and dendritic spine alterations in Alzheimer models.
    Moolman DL; Vitolo OV; Vonsattel JP; Shelanski ML
    J Neurocytol; 2004 May; 33(3):377-87. PubMed ID: 15475691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EphA4 loss improves social memory performance and alters dendritic spine morphology without changes in amyloid pathology in a mouse model of Alzheimer's disease.
    Poppe L; Rué L; Timmers M; Lenaerts A; Storm A; Callaerts-Vegh Z; Courtand G; de Boer A; Smolders S; Van Damme P; Van Den Bosch L; D'Hooge R; De Strooper B; Robberecht W; Lemmens R
    Alzheimers Res Ther; 2019 Dec; 11(1):102. PubMed ID: 31831046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synaptic contact number and size in stratum radiatum CA1 of APP/PS1DeltaE9 transgenic mice.
    West MJ; Bach G; Søderman A; Jensen JL
    Neurobiol Aging; 2009 Nov; 30(11):1756-76. PubMed ID: 18336954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyloid beta: a putative intra-spinal microtubule-depolymerizer to induce synapse-loss or dentritic spine shortening in Alzheimer's disease.
    Mitsuyama F; Futatsugi Y; Okuya M; Karagiozov K; Peev N; Kato Y; Kanno T; Sano H; Koide T
    Ital J Anat Embryol; 2009; 114(2-3):109-20. PubMed ID: 20198823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability of the distribution of spines containing drebrin A in the sensory cortex layer I of mice expressing mutated APP and PS1 genes.
    Mahadomrongkul V; Huerta PT; Shirao T; Aoki C
    Brain Res; 2005 Dec; 1064(1-2):66-74. PubMed ID: 16325786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early Activation of Experience-Independent Dendritic Spine Turnover in a Mouse Model of Alzheimer's Disease.
    Heiss JK; Barrett J; Yu Z; Haas LT; Kostylev MA; Strittmatter SM
    Cereb Cortex; 2017 Jul; 27(7):3660-3674. PubMed ID: 27365298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Various dendritic abnormalities are associated with fibrillar amyloid deposits in Alzheimer's disease.
    Grutzendler J; Helmin K; Tsai J; Gan WB
    Ann N Y Acad Sci; 2007 Feb; 1097():30-9. PubMed ID: 17413007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonin fibre sprouting and increase in serotonin transporter immunoreactivity in the CA1 area of hippocampus in a triple transgenic mouse model of Alzheimer's disease.
    Noristani HN; Olabarria M; Verkhratsky A; Rodríguez JJ
    Eur J Neurosci; 2010 Jul; 32(1):71-9. PubMed ID: 20576032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for altered dendritic spine compartmentalization in Alzheimer's disease and functional effects in a mouse model.
    Androuin A; Potier B; Nägerl UV; Cattaert D; Danglot L; Thierry M; Youssef I; Triller A; Duyckaerts C; El Hachimi KH; Dutar P; Delatour B; Marty S
    Acta Neuropathol; 2018 Jun; 135(6):839-854. PubMed ID: 29696365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Region-specific changes in the microanatomy of single dendritic spines over time might account for selective memory alterations in ageing hAPPsweTg2576 mice, a mouse model for Alzheimer disease.
    Middei S; Restivo L; Caprioli A; Aceti M; Ammassari-Teule M
    Neurobiol Learn Mem; 2008 Sep; 90(2):467-71. PubMed ID: 18515161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased densities of resting and activated microglia in the dentate gyrus follow senile plaque formation in the CA1 subfield of the hippocampus in the triple transgenic model of Alzheimer's disease.
    Rodríguez JJ; Noristani HN; Hilditch T; Olabarria M; Yeh CY; Witton J; Verkhratsky A
    Neurosci Lett; 2013 Sep; 552():129-34. PubMed ID: 23827221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different dendrite and dendritic spine alterations in basal and apical arbors in mutant human amyloid precursor protein transgenic mice.
    Alpár A; Ueberham U; Brückner MK; Seeger G; Arendt T; Gärtner U
    Brain Res; 2006 Jul; 1099(1):189-98. PubMed ID: 16781686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hippocampal neuron loss exceeds amyloid plaque load in a transgenic mouse model of Alzheimer's disease.
    Schmitz C; Rutten BP; Pielen A; Schäfer S; Wirths O; Tremp G; Czech C; Blanchard V; Multhaup G; Rezaie P; Korr H; Steinbusch HW; Pradier L; Bayer TA
    Am J Pathol; 2004 Apr; 164(4):1495-502. PubMed ID: 15039236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial amyloid-beta levels are associated with the extent of mitochondrial dysfunction in different brain regions and the degree of cognitive impairment in Alzheimer's transgenic mice.
    Dragicevic N; Mamcarz M; Zhu Y; Buzzeo R; Tan J; Arendash GW; Bradshaw PC
    J Alzheimers Dis; 2010; 20 Suppl 2():S535-50. PubMed ID: 20463404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brilliant Blue G improves cognition in an animal model of Alzheimer's disease and inhibits amyloid-β-induced loss of filopodia and dendrite spines in hippocampal neurons.
    Chen X; Hu J; Jiang L; Xu S; Zheng B; Wang C; Zhang J; Wei X; Chang L; Wang Q
    Neuroscience; 2014 Oct; 279():94-101. PubMed ID: 25193238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.